Publication Cover
AIDS Care
Psychological and Socio-medical Aspects of AIDS/HIV
Volume 35, 2023 - Issue 4
185
Views
0
CrossRef citations to date
0
Altmetric
Research Article

“I’ve been 95% safe”: perspectives on HIV pre-exposure prophylaxis at a drug detoxification center: a qualitative study

ORCID Icon, ORCID Icon, , ORCID Icon, ORCID Icon & ORCID Icon
Pages 461-465 | Received 11 Mar 2021, Accepted 13 Jan 2022, Published online: 02 Feb 2022

References

  • Allen, S. T., O'Rourke, A., White, R. H., Smith, K. C., Weir, B., Lucas, G. M., Sherman, S. G., & Grieb, S. M. (2020). Barriers and facilitators to PrEP use among people who inject drugs in rural Appalachia: A qualitative study. AIDS and Behavior, 24(6), 1942–1950. https://doi.org/10.1007/s10461-019-02767-3
  • Alpren, C., Dawson, E. L., John, B., Cranston, K., Nivedha Panneer, H., Fukuda, D., Roosevelt, R. K., Klevens, M., Bryant, J., Peters, P. J., Lyss, S. B., Switzer, W. M., Burrage, A., Murray, A., Agnew-Brune, C., Stiles, T., McClung, P., Campbell, E. M., Breen, C., … Buchacz, K. (2020). Opioid use fueling HIV transmission in an urban setting: An outbreak of HIV infection among people who inject drugs—Massachusetts, 2015–2018. American Journal of Public Health, 110(1), 37–44. https://doi.org/10.2105/AJPH.2019.305366
  • Assoumou, S. A., Paniagua, S. M., Gonzalez, P., Wang, J., Beckwith, C. G., White, L. F., Taylor, J. L., Coogan, K., Samet, J. H., & Linas, B. P. (2021). HIV pre-exposure prophylaxis and buprenorphine at a drug detoxification center during the opioid epidemic: Opportunities and challenges. AIDS and Behavior, 25(8), 2591–2598. https://doi.org/10.1007/s10461-021-03220-0. Epub 2021 Mar 22. PMID: 33751315; PMCID: PMC8531371.
  • Assoumou, S. A., Paniagua, S. M., Linas, B. P., Wang, J., Samet, J. H., Hall, J., White, L. F., & Beckwith, C. G. (2020). Rapid versus laboratory-based testing for HIV and hepatitis C at a drug detoxification treatment center: A randomized trial. The Journal of Infectious Diseases, 222(Suppl 5), S376–S383. https://doi.org/10.1093/infdis/jiaa162. PMID: 32877557; PMCID: PMC7566618.
  • Assoumou, S. A., Sian, C. R., Gebel, C. M., Linas, B. P., Samet, J. H., & Bernstein, J. A. (2021). Patients at a drug detoxification center share perspectives on how to increase hepatitis C treatment uptake: A qualitative study. Drug and Alcohol Dependence, 220, 108526. https://doi.org/10.1016/j.drugalcdep.2021.108526. Epub 2021 Jan 11. PMID: 33465604; PMCID: PMC8064807.
  • Bazzi, A. R., Biancarelli, D. L., Childs, E., Drainoni, M. L., Edeza, A., Salhaney, P., Mimiaga, M. J., & Biello, K. B. (2018). Limited knowledge and mixed interest in pre-exposure prophylaxis for HIV prevention among people who inject drugs. AIDS Patient Care and STDs, 32(12), 529–537. https://doi.org/10.1089/apc.2018.0126
  • Biello, K. B., Bazzi, A. R., Mimiaga, M. J., Biancarelli, D. L., Edeza, A., Salhaney, P., Childs, E., & Drainoni, M. L. (2018). Perspectives on HIV pre-exposure prophylaxis (PrEP) utilization and related intervention needs among people who inject drugs. Harm Reduction Journal, 15(1), 55. https://doi.org/10.1186/s12954-018-0263-5
  • Center for Substance Abuse Treatment. Detoxification and Substance Abuse Treatment. (2006). Treatment Improvement Protocol (TIP) Series 45. DHHS Publication No. (SMA) 06-4131. Rockville, MD: Substance Abuse and Mental Health Services Administration.
  • Centers for Disease Control and Prevention. (2020). Recent HIV clusters and outbreaks across the united states among people who inject drugs and considerations during the COVID-19 pandemic. Retrieved December 21 2021. From https://emergency.cdc.gov/han/2020/han00436.asp
  • Earlywine, J. J., Bazzi, A. R., Biello, K. B., & Klevens, R. M. (2020). High prevalence of indications for pre-exposure prophylaxis among people who inject drugs in Boston, Massachusetts. American Journal of Preventive Medicine, 60(3), 369–378. https://doi.org/10.1016/j.amepre.2020.09.011. Epub 2020 Nov 21. PMID: 33229144; PMCID: PMC7902399.
  • Martin, M., Vanichseni, S., Suntharasamai, P., Sangkum, U., Mock, P. A., Chaipung, B., Worrajittanon, D., Leethochawalit, M., Chiamwongpaet, S., Kittimunkong, S., Gvetadaze, R. J., McNicholl, J. M., Paxton, L. A., Curlin, M. E., Holtz, T. H., Samandari, T., & Choopanya, K. (2016). Factors associated with the uptake of and adherence to HIV pre-exposure prophylaxis in people. The Lancet HIV, 4(2), e59–e66. https://doi.org/10.1016/S2352-3018(16)30207-7
  • Sullivan, L. E., Moore, B. A., Chawarski, M. C., Pantalon, M. V., Barry, D., O'Connor, P. G., Schottenfeld, R. S., & Fiellin, D. A. (2008). Buprenorphine/naloxone treatment in primary care is associated with decreased human immunodeficiency virus risk behaviors. Journal of Substance Abuse Treatment, 35(1), 87–92. https://doi.org/10.1016/j.jsat.2007.08.004. PubMed PMID: 17933486; PMCID: PMC2587397.
  • US Preventive Services Task Force (USPSTF). (2019). Preexposure prophylaxis for the prevention of HIV infection: US preventive services task force recommendation statement. JAMA, 321(22), 2203–2213. https://doi.org/10.1001/jama.2019.6390
  • Vaismoradi, M., Turunen, H., & Bondas, T. (2013). Content analysis and thematic analysis: Implications for conducting a qualitative descriptive study. Nursing & Health Sciences, 15(3), 398–405. https://doi.org/10.1111/nhs.12048. PMID: 23480423.
  • Walters, S. M., Kral, A. H., Simpson, K. A., Wenger, L., & Bluthenthal, R. N. (2020). HIV pre-exposure prophylaxis prevention awareness, willingness, and perceived barriers among people who inject drugs in Los Angeles and San Francisco, CA, 2016–2018. Substance Use & Misuse, 55(14), 2409–2419. https://doi.org/10.1080/10826084.2020.1823419. Epub 2020 Sep 23. PMID: 32962490; PMCID: PMC7665852.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.